EGFR and hepatocellular carcinoma: In HCC, MAPKAPK5-AS1 upregulated PLAG1 like zinc finger 2 (PLAGL2) expression by acting as a ceRNA to decoy miR-154-5p, thereby activating EGFR/AKT signaling and participating in HCC progression [25].